289608d4_al_Reserve_Bank_of_Minneapolis__Solution
[Pros] Less expensive drugs. [Cons] Legal challenges by manufacturers (though federal courts have recently rejected several challenges). Price caps may discourage research. [Solution] 
State negotiates discount prices with pharmaceutical companies. Companies not offering discounts may face price caps.
A matrix of options | Federal Reserve Bank of Minneapolis
Solution